Tamotsu Yoshiyama

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double‐blind, placebo‐controlled trial

J. Satoh, Soroku Yagihashi, Masayuki Baba et al. · Diabetic Medicine · 2010 · 151 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease

Michael Hüll, Carl Sadowsky, Heii Arai et al. · Current Alzheimer Research · 2017 · 61 citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer’ s Disease: Results from Two Phase 2 Studies

Heii Arai, Hideo Suzuki, Tamotsu Yoshiyama · Current Alzheimer Research · 2015 · 58 citations

Medicine, Neurology, Pharmacology +17

Pregabalin Treatment for Peripheral Neuropathic Pain

Setsuro Ogawa, Jo Satoh, Akio Arakawa et al. · Drug Safety · 2012 · 48 citations

Nursing, Neurology, Pharmacotherapy +14

An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain

Kenji Onouchi, Kazumasa Yokoyama, Tamotsu Yoshiyama et al. · Journal of Pain Research · 2014 · 41 citations · Full text

Medicine, Neurology, Pharmacotherapy +16